FBInvestor
Stocks / Therapeuticsmd Inc
Institutional Ownership

Therapeuticsmd Inc

CUSIP 88338N206COM NEWTXMDQ1 2026

13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
25.7%
Max % of class reported
Institutional Holders
46
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

7 filings · latest Feb 12, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 12, 2025Clearline Capital LP13G11.0%635.2KSEC
2Nov 12, 2024Clearline Capital LP13G5.5%636.6KSEC
3Nov 17, 2023Rubric Capital Management LP13D/A25.7%2.95MSEC
4Jun 30, 2023Rubric Capital Management LP13D/A19.6%2.07MSEC
5Aug 30, 2022Rubric Capital Management LP13D/A18.3%1.72MSEC
6Aug 8, 2022Rubric Capital Management LP13D18.3%1.72MSEC
7Jul 8, 2022Blackrock Inc.13G/A1.4%122.1KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →